Therapy News and Research

RSS

Scientist receives € 2M Consolidator Grant for creation of new anti-tumour drugs

scar Fern-ndez-Capetillo's research group has developed compounds that only a few weeks ago were licensed by the Spanish National Cancer Research Centre (CNIO) to a pharmaceutical company for the creation of new anti-tumour drugs.

16 Jan 2014

Varian Medical Systems' updated ProBeam proton therapy system gets FDA clearance

Varian Medical Systems has received FDA 510(k) clearance for its updated ProBeam proton therapy system.

15 Jan 2014

FAMPYRA now available in Ireland for symptomatic treatment of walking impairment in MS patients

Biogen Idec today announced that FAMPYRA (prolonged-release fampridine tablets) has been made available in Ireland for the symptomatic treatment of walking impairment in adults with Multiple Sclerosis. FAMPYRA is a prescription drug and is licensed for use in all types of the disease, including the progressive forms. FAMPYRA is available by way of retail pharmacy on a private payment basis.

15 Jan 2014

Cedars-Sinai investigators identify new molecular abnormalities in diabetic cornea

Investigators at the Cedars-Sinai Regenerative Medicine Institute have identified new molecular abnormalities in the diabetic cornea that could contribute to eye problems in affected patients. With this new knowledge, investigators aim to accelerate the process of healing and repair in damaged corneas to ultimately reverse the effects of diabetes-induced eye complications.

15 Jan 2014

New minimally invasive procedure for AF patients who are intolerant of blood-thinning medications

Sanford Heart Hospitals in Fargo and Sioux Falls now provide a new, minimally invasive procedure for atrial fibrillation (AF) patients who are intolerant of blood-thinning medications. Atrial fibrillation is a heart disorder that affects nearly 3 million adults in the United States.

15 Jan 2014

Research paper highlights the role of T-cells in HIV

Ryan Zurakowski, assistant professor of electrical and computer engineering at the University of Delaware, is co-author of a paper appearing in Nature Medicine on Jan. 12 highlighting the role of T-cells in HIV.

15 Jan 2014

Research reveals new therapy for preventing production of sphingolipids by lymphoma cells

Christopher Parsons, MD, Director of the HIV Malignancies Program at LSU Health Sciences Center New Orleans, is the senior author of a paper that is the first to report that specialized fat (lipid) molecules, called sphingolipids, play a key role in the survival of aggressive lymphomas caused by viruses.

15 Jan 2014

FDA approves Farxiga tablets to improve glycemic control in adults with type 2 diabetes mellitus

AstraZeneca and Bristol-Myers Squibb Company announced the U.S. Food and Drug Administration approved Farxiga™ [far-SEE-ga] (dapagliflozin), a once-daily oral treatment indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

13 Jan 2014

HoLEP effective for overactive bladder symptoms

Research shows that Holmium laser enucleation of the prostate is effective in improving overactive bladder symptoms and urodynamic parameters in men with benign prostatic hyperplasia.

13 Jan 2014

Persistent insomnia symptom risk high

Insomnia symptoms are often persistent, report researchers who found that targeting sleep-interfering behaviors may be one method of prevention.

13 Jan 2014

BRAF mutation associated with other cancers appears to drive papillary craniopharyngiomas

A team led by investigators from Massachusetts General Hospital, Brigham and Women's Hospital and the Broad Institute has found that a gene mutation associated with several types of cancer also may be responsible for a rare but debilitating brain tumor called papillary craniopharyngioma.

13 Jan 2014

UMMS researchers commissioned by Alpha-1 Project to develop PiZ antibody

Researchers at the University of Massachusetts Medical School (UMMS) have been commissioned by the Alpha-1 Project (TAP) to develop a PiZ antibody. The antibody will be used to track the presence of mutant alpha-1 PiZ protein in human blood serum, an essential tool in testing potential therapies for Alpha-1 Antitrypsin Deficiency (Alpha-1).

13 Jan 2014

Scientists discover genetic signature mechanism in immune system as driving force for childhood leukaemia

Scientists have discovered a genetic signature that implicates a key mechanism in the immune system as a driving force for a type of childhood leukaemia.

13 Jan 2014

Nonsurgical treatment improves symptoms in women with pelvic floor dysfunction

One in three women suffer from pelvic floor dysfunction, a range of symptoms which include bladder and bowel problems as well as pelvic pain, according to the American Urogynecologic Society. Now, University of Missouri researchers have demonstrated that a comprehensive, nonsurgical treatment significantly improves symptoms in women with PFD.

10 Jan 2014

State highlights: Calif. Governor's budget to include $670M in new Medi-Cal spending; Mass. launches new electronic health records updates

When he unveils his new budget plan Thursday, Gov. Jerry Brown will propose billions of dollars in new spending on schools, health care, social services and environmental programs as California reaps the benefits of an economic turnaround. … The proposed budget includes $670 million more for Medi-Cal, the state's public health care program, which is expanding as part of President Obama's federal overhaul. The program is expected to serve a quarter of California's residents next year.

10 Jan 2014

Patient's own bone-marrow stromal cells could treat multi-drug resistant TB

Findings of a preliminary study published in The Lancet Respiratory Medicine suggest that a patient’s own bone-marrow stromal (stem) cells could be used to treat multidrug-resistant (MDR) and extensively-drug (XDR) tuberculosis.

10 Jan 2014

Study: HIV-specific poison kills persisting HIV-infected cells during antiretroviral therapy

A team including University of North Carolina and NIH scientists has demonstrated in a mouse model that an HIV-specific poison can kill cells in which the virus is actively reproducing despite antiretroviral therapy.

10 Jan 2014

Neurovance announces interim results from phase 2a pilot study of EB-1020 SR in patients with all subtypes of ADHD

Neurovance Inc. today announced interim results from its phase 2a pilot study of EB-1020 SR in adult patients with all subtypes of ADHD. With the four week trial fully enrolled and dosing completed in the majority of patients, the results indicate a statistically significant improvement in ADHD symptoms.

10 Jan 2014

Researchers deploy potential new weapon against HIV

Researchers at the UNC School of Medicine have deployed a potential new weapon against HIV - a combination therapy that targets HIV-infected cells that standard therapies cannot kill.

10 Jan 2014

Synta initiates three multicenter trials to evaluate ganetespib with chemotherapy for AML and MDS

Synta Pharmaceuticals Corp. today announced the initiation of three multicenter, randomized trials supported by the Leukemia & Lymphoma Research Fund and Cancer Research UK, evaluating ganetespib in combination with chemotherapy in first-line treatment of patients with AML and high risk MDS.

10 Jan 2014

Therapy News and Research

Scientist receives € 2M Consolidator Grant for creation of new anti-tumour drugs

Varian Medical Systems' updated ProBeam proton therapy system gets FDA clearance

FAMPYRA now available in Ireland for symptomatic treatment of walking impairment in MS patients

Cedars-Sinai investigators identify new molecular abnormalities in diabetic cornea

New minimally invasive procedure for AF patients who are intolerant of blood-thinning medications

Research paper highlights the role of T-cells in HIV

Research reveals new therapy for preventing production of sphingolipids by lymphoma cells

FDA approves Farxiga tablets to improve glycemic control in adults with type 2 diabetes mellitus

HoLEP effective for overactive bladder symptoms

Persistent insomnia symptom risk high

BRAF mutation associated with other cancers appears to drive papillary craniopharyngiomas

UMMS researchers commissioned by Alpha-1 Project to develop PiZ antibody

Scientists discover genetic signature mechanism in immune system as driving force for childhood leukaemia

Nonsurgical treatment improves symptoms in women with pelvic floor dysfunction

State highlights: Calif. Governor's budget to include $670M in new Medi-Cal spending; Mass. launches new electronic health records updates

Patient's own bone-marrow stromal cells could treat multi-drug resistant TB

Study: HIV-specific poison kills persisting HIV-infected cells during antiretroviral therapy

Neurovance announces interim results from phase 2a pilot study of EB-1020 SR in patients with all subtypes of ADHD

Researchers deploy potential new weapon against HIV

Synta initiates three multicenter trials to evaluate ganetespib with chemotherapy for AML and MDS

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

Latest News